A personalized mHealth training application to increase physical activity during and after cardiac rehabilitation.

A personalized mHealth training application to increase physical activity during and after cardiac rehabilitation. - Cardiac RehApp

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON49556

Enrollment

132

Registered

2020-04-16

Start date

2020-12-08

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease coronary heart disease

Interventions

Subjects in group 2(CR+), 3 (+CR) and 4(+CR+) will be asked to perform physical activity in their home situation using a mHealth application called Virtual Training® (introduction video: https://www

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Participants must be older than 18 years of age * Diagnosed with coronary artery disease (ST-elevation myocardial infarction (STEMI) * non-ST-elevation myocardial infarction (NSTEMI) * UAP (unstable angina pectoris) * stable angina pectoris (AP)) * Being able to operate a smartphone with the Virtual Training application. * Referred to cardiac rehabilitation * Able to understand and perform the study procedures.

Exclusion criteria

Exclusion criteria: * Not in the possession of a smartphone, or unable to operate a smartphone for the purpose of the trial (because of vision, hearing, and cognitive or dexterity impairment). * Have no (mobile) internet access at their place of residence. * Have contraindications to exercise rehabilitation. * Subjects who have severe orthopaedic that restricts physical activity. * Unable to give informed consent * Language barrier

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the change in physical activity volume (min/week) between the four groups at post-CR and after follow-up. Physical activity patterns will be objectively measured with a validated activity-monitor (ActivPAL micro, PAL technologies, Glasgow, United Kingdom).	—

Secondary

Measure	Time frame
Secondary study endpoints are: * The change in total sitting time (min/week) between the four groups at post-CR and after follow-up. * Physical fitness between the four groups at post-CR and after follow-up measured with a submaximal exercise test (Astrand-rhyming) * Handgrip strength * Quality of life (Quality of life questionnaire - heart) * Cardiac anxiety (Cardiac Anxiety Questionnaire). * Laboratory values (lipid spectrum, cardiac biomarkers)	—

Measure

Time frame

Secondary study endpoints are: * The change in total sitting time (min/week) between the four groups at post-CR and after follow-up. * Physical fitness between the four groups at post-CR and after follow-up measured with a submaximal exercise test (Astrand-rhyming) * Handgrip strength * Quality of life (Quality of life questionnaire - heart) * Cardiac anxiety (Cardiac Anxiety Questionnaire). * Laboratory values (lipid spectrum, cardiac biomarkers)

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)